bf/NASDAQ:ATXS_icon.jpeg

    COM:ASTRIATX

    Astria Therapeutics

    • Stock

    USD

    Last Close

    5.21

    25/04 20:00

    Market Cap

    231.94M

    Beta: -

    Volume Today

    292.65K

    Avg: -

    Preview

    Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

    Subscribe NowHelp
    Dec '14
    Dec '15
    Dec '16
    Dec '17
    Dec '18
    Dec '19
    Dec '20
    Dec '21
    Dec '22
    Dec '23
    average inventory
    average payables
    891.50K
    -
    1.23M
    37.97%
    1.37M
    11.10%
    1.09M
    20.31%
    1.09M
    0.14%
    1.30M
    19.44%
    1.37M
    5.22%
    1.55M
    13.13%
    1.17M
    24.38%
    1.15M
    1.88%
    average receivables
    book value per share
    -505.83
    -
    376.72
    174.48%
    107.53
    71.46%
    32.63
    69.65%
    41.48
    27.10%
    19.14
    53.86%
    13.30
    30.52%
    13.70
    3.06%
    15.13
    10.41%
    capex per share
    -1.58
    -
    -3.14
    98.96%
    -1.70
    45.98%
    -0.16
    90.70%
    0.02
    113.55%
    -0.01
    130.09%
    -0.01
    67.82%
    -0.00
    78.19%
    -0.01
    164.53%
    capex to depreciation
    -0.92
    -
    -2.08
    126.70%
    -1.16
    44.24%
    -0.19
    83.86%
    0.15
    180.67%
    -0.46
    405.13%
    capex to operating cash flow
    0.01
    -
    0.01
    26.51%
    0.01
    1.14%
    0.00
    84.80%
    -0.00
    136.12%
    0.00
    158.88%
    0.00
    124.92%
    0.00
    31.44%
    0.00
    200.13%
    0.00
    82.53%
    capex to revenue
    -0.11
    -
    cash per share
    101.56
    -
    468.40
    361.19%
    142.43
    69.59%
    45.30
    68.20%
    44.59
    1.55%
    19.42
    56.46%
    14.69
    24.35%
    14.06
    4.27%
    15.49
    10.14%
    days of inventory on hand
    days payables outstanding
    days sales outstanding
    debt to assets
    0.30
    -
    0.14
    53.16%
    0.14
    2.15%
    0.14
    2.66%
    0.05
    -
    0.02
    59.13%
    0.00
    87.01%
    0.00
    42.24%
    0.00
    68.27%
    debt to equity
    -0.06
    -
    0.18
    372.63%
    0.20
    11.02%
    0.21
    6.86%
    0.06
    -
    0.03
    59.22%
    0.00
    88.40%
    0.00
    42.24%
    0.00
    68.12%
    dividend yield
    0.51
    -
    earnings yield
    -0.19
    -
    -0.51
    163.38%
    -0.62
    20.28%
    -0.85
    37.63%
    -1.17
    38.26%
    -0.40
    66.14%
    -0.94
    138.03%
    -0.63
    33.54%
    -0.23
    63.26%
    enterprise value
    102.73M
    -
    9.94M
    90.32%
    40.72M
    309.65%
    18.42M
    54.77%
    6.80M
    63.10%
    58.54M
    761.45%
    15.39M
    73.71%
    -38.04M
    347.18%
    198.12M
    620.86%
    -175.20M
    188.43%
    enterprise value over ebitda
    -4.79
    -
    -0.31
    93.45%
    -1.17
    272.29%
    -0.69
    40.78%
    -0.26
    61.74%
    -2.23
    741.24%
    -0.41
    81.56%
    -0.28
    31.08%
    -3.70
    1,207.02%
    2.11
    156.99%
    ev to operating cash flow
    -5.03
    -
    -0.33
    93.37%
    -1.24
    271.44%
    -0.69
    44.62%
    -0.29
    57.80%
    -2.20
    660.80%
    -0.47
    78.50%
    1.26
    366.31%
    -4.55
    460.75%
    2.56
    156.25%
    ev to sales
    36.83
    -
    free cash flow per share
    -142.91
    -
    -225.42
    57.73%
    -123.17
    45.36%
    -74.42
    39.58%
    -27.83
    62.60%
    -14.24
    48.83%
    -10.63
    25.34%
    -3.38
    68.20%
    -2.98
    11.74%
    free cash flow yield
    -0.18
    -
    -0.47
    158.58%
    -0.57
    20.02%
    -0.83
    46.40%
    -1.06
    27.51%
    -0.40
    62.16%
    -0.83
    106.18%
    -0.63
    24.25%
    -0.20
    68.05%
    graham net net
    -514.80
    -
    365.96
    171.09%
    101.31
    72.32%
    28.40
    71.96%
    39.58
    39.34%
    16.17
    59.14%
    12.47
    22.88%
    13.48
    8.09%
    14.84
    10.12%
    graham number
    1.31K
    -
    1.44K
    9.39%
    567.90
    60.47%
    235.80
    58.48%
    169.28
    28.21%
    77.81
    54.04%
    60.21
    22.61%
    32.29
    46.38%
    34.18
    5.86%
    income quality
    0.93
    -
    0.91
    2.11%
    0.91
    0.20%
    0.98
    7.63%
    0.91
    7.51%
    1.01
    11.41%
    0.87
    13.81%
    0.15
    82.24%
    0.84
    442.93%
    0.94
    11.81%
    intangibles to total assets
    0
    -
    0
    0
    0
    0
    0
    0
    0
    0
    0
    interest coverage
    -105.25
    -
    -32.37
    69.24%
    -42.48
    31.24%
    -58.65
    38.04%
    -263.71
    349.67%
    32.06
    -
    interest debt per share
    34.30
    -
    74.05
    115.87%
    24.25
    67.26%
    8.14
    66.43%
    0.12
    98.54%
    1.21
    916.92%
    0.34
    71.67%
    0.04
    88.04%
    -0.05
    222.09%
    inventory turnover
    invested capital
    -0.06
    -
    0.18
    372.63%
    0.20
    11.02%
    0.21
    6.86%
    0.06
    -
    0.03
    59.22%
    0.00
    88.40%
    0.00
    42.24%
    0.00
    68.12%
    market cap
    112.65M
    -
    63.77M
    43.39%
    58.59M
    8.12%
    32.31M
    44.86%
    22.09M
    31.62%
    66.19M
    199.63%
    39.27M
    40.66%
    48.11M
    22.50%
    217.70M
    352.54%
    net current asset value
    -74.00M
    -
    49.85M
    167.37%
    28.41M
    43.02%
    11.36M
    60.01%
    34.69M
    205.41%
    32.90M
    5.16%
    39.54M
    20.18%
    121.87M
    208.24%
    217.02M
    78.07%
    239.39M
    10.31%
    net debt to ebitda
    0.46
    -
    1.70
    267.42%
    0.51
    69.83%
    0.52
    1.76%
    0.60
    14.17%
    0.29
    51.18%
    0.64
    119.18%
    -0.64
    200.57%
    0.37
    157.05%
    2.11
    476.41%
    net income per share
    -151.53
    -
    -243.45
    60.66%
    -133.31
    45.24%
    -75.73
    43.19%
    -30.71
    59.45%
    -14.06
    54.21%
    -12.12
    13.81%
    -3.38
    72.10%
    -3.43
    1.49%
    operating cash flow per share
    -141.34
    -
    -222.28
    57.27%
    -121.47
    45.35%
    -74.26
    38.86%
    -27.85
    62.50%
    -14.23
    48.89%
    -10.62
    25.39%
    -3.38
    68.19%
    -2.98
    11.86%
    payables turnover
    receivables turnover
    research and ddevelopement to revenue
    37.36
    -
    return on tangible assets
    -1.37
    -
    -0.51
    62.94%
    -0.90
    76.51%
    -1.53
    70.49%
    -0.66
    56.80%
    -0.63
    4.90%
    -0.78
    24.34%
    -0.24
    69.70%
    -0.22
    8.08%
    -0.29
    31.59%
    revenue per share
    1.38
    -
    roe
    0.30
    -
    -0.65
    315.72%
    -1.24
    91.85%
    -2.32
    87.18%
    -0.74
    68.10%
    -0.73
    0.77%
    -0.91
    24.05%
    -0.25
    72.93%
    -0.23
    8.08%
    -0.30
    32.21%
    roic
    0.32
    -
    -0.55
    270.20%
    -1.05
    92.13%
    -1.93
    84.45%
    -0.77
    60.05%
    -0.67
    12.97%
    -0.87
    29.43%
    -0.25
    71.80%
    -0.23
    5.38%
    -0.34
    46.75%
    sales general and administrative to revenue
    17.82
    -
    shareholders equity per share
    -505.83
    -
    376.72
    174.48%
    107.53
    71.46%
    32.63
    69.65%
    41.48
    27.10%
    19.14
    53.86%
    13.30
    30.52%
    13.70
    3.06%
    15.13
    10.41%
    stock based compensation to revenue
    4.01
    -
    tangible asset value
    -73.05M
    -
    50.49M
    169.12%
    29.09M
    42.40%
    11.79M
    59.46%
    34.94M
    196.32%
    35.72M
    2.23%
    40.67M
    13.85%
    122.31M
    200.75%
    221.22M
    80.86%
    243.12M
    9.90%
    tangible book value per share
    -505.83
    -
    376.72
    174.48%
    107.53
    71.46%
    32.63
    69.65%
    41.48
    27.10%
    19.14
    53.86%
    13.30
    30.52%
    13.70
    3.06%
    15.13
    10.41%
    working capital
    10.79M
    -
    55.77M
    416.99%
    31.20M
    44.05%
    11.45M
    63.31%
    34.74M
    203.52%
    33.93M
    2.35%
    39.94M
    17.71%
    121.87M
    205.18%
    225.85M
    85.32%
    239.39M
    5.99%

    All numbers in USD (except ratios and percentages)